Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations von Bosse, Kristopher R., Maris, John M.

Volltext

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group von Irwin, Meredith S, Naranjo, Arlene, Zhang, Fan F, Cohn, Susan L, London, Wendy B, Gastier-Foster, Julie M, Ramirez, Nilsa C, Pfau, Ruthann, Reshmi, Shalini, Wagner, Elizabeth, Nuchtern, Jed, Asgharzadeh, Shahab, Shimada, Hiroyuki, Maris, John M, Bagatell, Rochelle, Park, Julie R, Hogarty, Michael D

Volltext

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome von Padovan-Merhar, Olivia M, Raman, Pichai, Ostrovnaya, Irina, Kalletla, Karthik, Rubnitz, Kaitlyn R, Sanford, Eric M, Ali, Siraj M, Miller, Vincent A, Mossé, Yael P, Granger, Meaghan P, Weiss, Brian, Maris, John M, Modak, Shakeel

Volltext

MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells von Altman, Brian J., Hsieh, Annie L., Sengupta, Arjun, Krishnanaiah, Saikumari Y., Stine, Zachary E., Walton, Zandra E., Gouw, Arvin M., Venkataraman, Anand, Li, Bo, Goraksha-Hicks, Pankuri, Diskin, Sharon J., Bellovin, David I., Simon, M. Celeste, Rathmell, Jeffrey C., Lazar, Mitchell A., Maris, John M., Felsher, Dean W., Hogenesch, John B., Weljie, Aalim M., Dang, Chi V.

Volltext

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy von Sotillo, Elena, Barrett, David M, Black, Kathryn L, Bagashev, Asen, Oldridge, Derek, Wu, Glendon, Sussman, Robyn, Lanauze, Claudia, Ruella, Marco, Gazzara, Matthew R, Martinez, Nicole M, Harrington, Colleen T, Chung, Elaine Y, Perazzelli, Jessica, Hofmann, Ted J, Maude, Shannon L, Raman, Pichai, Barrera, Alejandro, Gill, Saar, Lacey, Simon F, Melenhorst, Jan J, Allman, David, Jacoby, Elad, Fry, Terry, Mackall, Crystal, Barash, Yoseph, Lynch, Kristen W, Maris, John M, Grupp, Stephan A, Thomas-Tikhonenko, Andrei

Volltext

Neuroblastoma von Maris, John M, MD, Hogarty, Michael D, MD, Bagatell, Rochelle, MD, Cohn, Susan L, Prof

Volltext

Recent Advances in Neuroblastoma von Maris, John M

Volltext

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study von Mossé, Yael P, Dr, Lim, Megan S, MD, Voss, Stephan D, MD, Wilner, Keith, PhD, Ruffner, Katherine, MD, Laliberte, Julie, Rolland, Delphine, Balis, Frank M, Prof, Maris, John M, Prof, Weigel, Brenda J, MD, Ingle, Ashish M, MS, Ahern, Charlotte, PhD, Adamson, Peter C, Prof, Blaney, Susan M, Prof

Volltext

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations von Brady, Samuel W., Liu, Yanling, Ma, Xiaotu, Gout, Alexander M., Hagiwara, Kohei, Zhou, Xin, Wang, Jian, Macias, Michael, Chen, Xiaolong, Easton, John, Mulder, Heather L., Rusch, Michael, Wang, Lu, Nakitandwe, Joy, Lei, Shaohua, Davis, Eric M., Naranjo, Arlene, Cheng, Cheng, Maris, John M., Downing, James R., Cheung, Nai-Kong V., Hogarty, Michael D., Dyer, Michael A., Zhang, Jinghui

Volltext

11q deletion in neuroblastoma: a review of biological and clinical implications von Mlakar, Vid, Jurkovic Mlakar, Simona, Lopez, Gonzalo, Maris, John M, Ansari, Marc, Gumy-Pause, Fabienne

Volltext

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting von Park, Julie R, Bagatell, Rochelle, Cohn, Susan L, Pearson, Andrew D, Villablanca, Judith G, Berthold, Frank, Burchill, Susan, Boubaker, Ariane, McHugh, Kieran, Nuchtern, Jed G, London, Wendy B, Seibel, Nita L, Lindwasser, O Wolf, Maris, John M, Brock, Penelope, Schleiermacher, Gudrun, Ladenstein, Ruth, Matthay, Katherine K, Valteau-Couanet, Dominique

Volltext

Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial von Mody, Rajen, MD, Naranjo, Arlene, PhD, Van Ryn, Collin, MS, Yu, Alice L, Prof, London, Wendy B, PhD, Shulkin, Barry L, Prof, Parisi, Marguerite T, Prof, Servaes, Sabah-E-Noor, MD, Diccianni, Mitchell B, PhD, Sondel, Paul M, Prof, Bender, Julia G, MD, Maris, John M, Prof, Park, Julie R, Prof, Bagatell, Rochelle, Dr

Volltext

Children's Oncology Group's 2013 blueprint for research: Neuroblastoma von Park, Julie R., Bagatell, Rochelle, London, Wendy B., Maris, John M., Cohn, Susan L., Mattay, Katherine M., Hogarty, Michael

Volltext

Assessment of programmed death‐ligand 1 expression and tumor‐associated immune cells in pediatric cancer tissues von Majzner, Robbie G., Simon, Jason S., Grosso, Joseph F., Martinez, Daniel, Pawel, Bruce R., Santi, Mariarita, Merchant, Melinda S., Geoerger, Birgit, Hezam, Imene, Marty, Virginie, Vielh, Phillippe, Daugaard, Mads, Sorensen, Poul H., Mackall, Crystal L., Maris, John M.

Volltext

ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation von Qing, Guoliang, Li, Bo, Vu, Annette, Skuli, Nicolas, Walton, Zandra E., Liu, Xueyuan, Mayes, Patrick A., Wise, David R., Thompson, Craig B., Maris, John M., Hogarty, Michael D., Simon, M. Celeste

Volltext

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism von Oldridge, Derek A., Wood, Andrew C., Weichert-Leahey, Nina, Crimmins, Ian, Sussman, Robyn, Winter, Cynthia, McDaniel, Lee D., Diamond, Maura, Hart, Lori S., Zhu, Shizhen, Durbin, Adam D., Abraham, Brian J., Anders, Lars, Tian, Lifeng, Zhang, Shile, Wei, Jun S., Khan, Javed, Bramlett, Kelli, Rahman, Nazneen, Capasso, Mario, Iolascon, Achille, Gerhard, Daniela S., Guidry Auvil, Jaime M., Young, Richard A., Hakonarson, Hakon, Diskin, Sharon J., Thomas Look, A., Maris, John M.

Volltext

Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity von Yarmarkovich, Mark, Warrington, John M., Farrel, Alvin, Maris, John M.

Volltext

Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma von Bosse, Kristopher R., Raman, Pichai, Zhu, Zhongyu, Lane, Maria, Martinez, Daniel, Heitzeneder, Sabine, Rathi, Komal S., Kendsersky, Nathan M., Randall, Michael, Donovan, Laura, Morrissy, Sorana, Sussman, Robyn T., Zhelev, Doncho V., Feng, Yang, Wang, Yanping, Hwang, Jennifer, Lopez, Gonzalo, Harenza, Jo Lynne, Wei, Jun S., Pawel, Bruce, Bhatti, Tricia, Santi, Mariarita, Ganguly, Arupa, Khan, Javed, Marra, Marco A., Taylor, Michael D., Dimitrov, Dimiter S., Mackall, Crystal L., Maris, John M.

Volltext

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project von Schleiermacher, G, Mosseri, V, London, W B, Maris, J M, Brodeur, G M, Attiyeh, E, Haber, M, Khan, J, Nakagawara, A, Speleman, F, Noguera, R, Tonini, G P, Fischer, M, Ambros, I, Monclair, T, Matthay, K K, Ambros, P, Cohn, S L, Pearson, A D J

Volltext

One‐step deposition of nano‐to‐micron‐scalable, high‐quality digital image correlation patterns for high‐strain in‐situ multi‐microscopy testing von Hoefnagels, J.P.M., Maris, M.P.F.H.L., Vermeij, T.

Volltext